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ABSTRACT  Chondrocytes produce large pericellular coats  in vitro that can  be visualized  by 
the exclusion of particles,e.g.,  fixed erythrocytes, and that are  removed  by treatment with 
Streptomyces  hyaluronidase, which is specific for hyaluronate. In this study, we examined the 
kinetics of formation of these coats and the relationship of hyaluronate and proteoglycan to 
coat structure. Chondrocytes were isolated  from  chick tibia cartilage  by collagenase-trypsin 
digestion and were characterized by their morphology and by their synthesis of both type II 
collagen and high molecular weight proteoglycans. The degree of spreading of the chondro- 
cytes and the size of the coats were quantitated at various times subsequent to seeding by 
tracing  phase-contrast  photomicrographs  of the  cultures.  After  seeding,  the  chondrocytes 
attached themselves  to the  tissue  culture  dish  and  exhibited  coats  within  4  h.  The coats 
reached  a  maximum  size  after  3-4  d  and  subsequently  decreased  over  the  next 2-3  d. 
Subcultured chondrocytes produced a large coat only if passaged before 4 d.  Both primary 
and first passage cells, with or without coats, produced type II collagen but not type I collagen 
as determined  by enzyme-linked  immunosorbent  assay. Treatment with  Streptomyces  hya- 
luronidase (1.0 mU/ml,  15 min),  which completely  removed  the coat, released  58% of the 
chondroitin sulfate  but only 9% of the proteins associated with the cell surface. The proteins 
released  by hyaluronidase were not digestible by bacterial  collagenase.  Monensin and cyclo- 
heximide (0.01-10 p,M, 48 h) caused a dose-dependent decrease in coat size that was linearly 
correlated to synthesis  of cell surface  hyaluronate (r =  0.98)  but not chondroitin sulfate  (r = 
0.2). We conclude that the coat surrounding chondrocytes is dependent on hyaluronate for 
its structure and that hyaluronate retains a large proportion of the proteoglycan in the coat. 
In cartilage, chondrocytes lie within lacunae that are in turn 
surrounded by a territorial matrix that exhibits intense baso- 
philia compared with the interterritorial matrix more distant 
from the cells. The lacunar area contains a narrow pericellular 
region of matrix, the ultrastructure of which differs from the 
adjacent territorial matrix (1-3). This pericellular matrix is 
l-3-um thick,  whereas the territorial matrix is often much 
larger, up to 50-#m thick (2). The periceUular and territorial 
matrices form the interface between the chondrocyte surface 
and the bulk of the tissue, i.e., the interterritorial matrix, and 
thus  are  presumed  to  be  important  in  control  of matrix 
composition and turnover. They differ considerably in struc- 
ture from the interterritorial matrix (2-5), and vary in struc- 
ture according to site and physiological state of the cartilage 
(4-6). Two types of  experimental evidence have indicated that 
hyaluronate may play an important role in the assembly of 
these  matrices.  First,  hyaluronate-proteoglycan interactions 
have been found to mediate the retention of proteoglycan at 
the cell surface of chondrocytes (7-9).  Second, hyaluronate 
interaction with the chondrocyte surface has been shown to 
influence proteoglycan synthesis and secretion (8,  10-12). 
Surrounding many types of cells in culture is a large peri- 
cellular coat,  10-20-~m thick,  which  can  be visualized by 
exclusion of particles, e.g., fixed erythrocytes (13-15). Hyalu- 
ronate is known to play a role in the structure of these coats 
because low concentrations  of Streptomyces hyaluronidase, 
an enzyme that degrades only hyaluronate (16), remove these 
coats (l 5) and drugs that inhibit hyaluronate synthesis prevent 
their formation (17,  18). We have found that chick embryo 
chondrocytes in culture make very large,  Streptomyces hya- 
luronidase-sensitive coats that may then provide an in vitro 
model for the pericellular and/or territorial matrices. In this 
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coats and the relationship of hyaluronate and proteoglycan to 
their structure. 
MATERIALS AND  METHODS 
Cell Cultures 
Chick chondrocytes  preparation  and culture  conditions  were based upon 
previously published techniques  (19). The tibia from 12-d--old chick embryos 
(stage 37) were dissected free of muscle and extraneous connective tissue. The 
cartilaginous portion of  the diaphysis was removed from within the periosteum 
and rinsed in 0.02 M Tris.-O.  15 M NaCI buffer, pH 7.5, and then with enzyme 
solution, 0.5% collagenase, 0.2% trypsin in the same buffer. The cartilage was 
digested three times with this enzyme solution  for 30 rain at 37"C. The cells 
were pelleted by eentrifugation  and washed  once  with Dulbeeeo's  modified 
Eagle's medium containing  10%  fetal bovine  serum and penicillin--strepto- 
mycin. The cells were cultured in the same medium at 37°C in 5% CO2/95% 
air. Ascorbate (50/~g/ml) was added to the cultures every 2 or 3 d. The drugs 
monensin  (Calbiochem-Behring Corp., La Joila, CA) and cycloheximide (Sigma 
Chemical  Co., St.  Louis, MO), were dissolved in ethanol  before addition  to 
cultures. The 3T3 cells were grown in the same medium and under the same 
conditions as described for the chondrocytes. 
DNA Content 
The DNA content of cultures was qoantitated  by the intercalated  fluores- 
cence ofethidium bromide (18, 20). Sperm whale DNA (Sigma Chemical Co.) 
was used as a standard.  1 ug of DNA was the lower limit of quantitation. 
Visualization of Coats 
A suspension of formalin-fixed erythrocytes (0.8 ml,  l0  s cells/ml  in 0.1% 
BSA in PBS) was added to a 35-mm dish of chondroeytes and the erythrocytes 
were allowed to settle for 10-20 min as described previously (15). The cultures 
were observed with a phase-contrast microscope and photographed. The coats 
were removed with 1 mU/mi ofStreptomyces  hyaluronidase (Miles Laboratory 
Inc., Elkland, IN) at 37°C for 30 min. 
Morphometric Analysis of Coats 
We determined  areas within the coat perimeter  (i.e., the area from which 
erythrocytes are excluded) and the cell perimeter,  termed "coat +  cell area" 
and  "cell  area,"  respectively, by  tracing  photomicrographs  on  a  digitizing 
graphics tablet connected to an Apple computer.  Relative coat size or thickness 
is defined by the ~coat/cell  ratio,"  i.e., the ratio  of the area within  the coat 
perimeter (the coat + cell area) to the area within the cell perimeter (cell area). 
A ratio of 1.0 would thus signify no detectable coat. Randomly chosen fields 
were photographed  for these measurements. 
Glycosaminoglycan Synthesis 
The incorporation  of [35S]sulfate and [3H]acetate into glycosaminogiycans 
of the cell surface and the  medium was measured.  After 24 h incorporation 
with  100  #Ci/ml  [3SS]sulfate or  20  #Ci/ml  [3H]acetate, the  medium  was 
removed, then the cell layer was washed twice and treated with 0.25% trypsin, 
0.02% EDTA in calcium- and magnesium-free PBS at 37"C for 15 min. The 
cell surface material (trypsinate) was separated from the cells by centrifugation. 
The medium and trypsinate were digested with  1 mg/ml of protease for 24 h 
at  50°C followed by boiling to inactivate  the protease.  Because of the  large 
amount of free isotope in the medium, the macromoleeules  in this fraction 
were precipitated with 3 vol of 1.3% potassium acetate in 95% ethanol (-200C, 
24 h) prior to assay. From each preparation  0.2-ml  aliquots  were incubated 
with or without 2 U of Streptomyces hyaluronidase at 50°C or 0.1 U chondroi- 
tinase ABC at 370C for 24 h. The labeled glycosaminoglycans were precipitated 
with 0.02 ml of a 10% cetylpyridinium chloride solution in the presence of 0.4 
ml of carrier  (0.5 mg/ml hyaluronate  and 0.25 mg/ml chondroitin  sulfate). 
After  1 h of incubation  at 37°C, the samples were centrifuged in a Beckman 
microfuge (10,000 g, 5 min [Beckman Instruments, Inc., Palo Alto, CA]). The 
pellets were washed twice with 0.05% cetylpyridinium  chloride, 0.05 M NaCI, 
then dissolved in 0.15 ml of methanol.  We measured the radioactivity in the 
solutions by adding  1.45 ml of scintillation cocktail into the microfuge tubes 
and counting the tubes in carrier vials in a Beckman LS-8100. 
The amount of labeled hyaluronate  was determined  from the difference in 
radioactivity  in the nondigested  sample and the Streptomyces hyaluronidase- 
digested sample.  Labeled chondroitin  sulfate was the difference between the 
Streptomyces  hyaluronidase-digested  and  the  chondroitinase  ABC-digested 
samples. 
Protein Synthesis 
NONCOLLAGENOUS PROTEIN:  Cultures were incubated for 24 h with 
[3H]proline (20 #Ci/mol,  10 #Ci/ml) and the medium and cells were harvested. 
BSA was added to aliquots of  each to give a concentration  of0.1%, and protein 
was then precipitated with trichloroacetic acid (10% final concentration)  at 4"C 
for 3 h. The samples were centrifuged in a microfuge for 3 rain (10,000 g) and 
the  pellet  was washed  twice with  10%  trichloroacetic  acid. The pellet was 
dissolved in 0.1  ml of 0.2 N NaOH then acidified with 0.02 ml of I N acetic 
acid.  Radioactivity  in  the  microfuge  tube  was measured  as  described  for 
glycosaminoglycan synthesis (above). The trypsinate  was separated from the 
cells by centrifugation  and the radioactivity  of an aliquot  of the supernatant 
was used as a measure of the residual protein at the cell surface. 
COLLAGEN:  Metabolically labeled collagen was quantitated  in the cell 
surface trypsinate and PBS incubation  medium from the above cultures by the 
susceptibility of trichloroacetic acid precipitable material to purified, protease- 
free bacterial collagenase. The difference between the nondigested sample and 
the digested sample was considered collagenous. The samples with trypsin were 
boiled before digestion with collagenase. Also, N-ethylmaleimide was added to 
all samples to prevent  possible nonspecific degradation.  Data were corrected 
for the 5.4 times greater proline content of collagen compared with the average 
content of other proteins (21). 
Identification and Quantitation  of Collagen Types 
SDS  PAGE:  Cultures  were incubated  with fresh medium containing  as- 
corbate  and [3H]proline (20.7 uCi/mol,  10 #Ci/ml medium).  After 24 h the 
medium was removed and the macromolecules were precipitated with ammo- 
nium sulfate (45% final concentration)  and then centrifuged (1,500 g, 15 min). 
The pellet was dissolved in 0.5 M acetic acid and dialyzed against the same at 
4"C. After 2 h, pepsin (0,1 mg/ml final concentration) was added to the sample, 
which was then digested and dialyzed at 4"C for 24 h. The sample was dialyzed 
against 0.01  M sodium phosphate,  pH 7.4, for 24 h. Aliquots were electro- 
phorased  on SDS polyacrylamide  slab gels (6%  acrylamide) as described by 
Laemmli (22). The gels were dried and placed in Enhancer  TM and the autora- 
diographs were developed. Radioactive rat tail type I collagen obtained  from 
Dr. C. Biswas (Tufts University School of Medicine) was used as a standard. 
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)t:  The relative 
inhibition  of color production  in an ELISA assay was used to calculate the 
amounts of type I and I1 collagens in culture medium.  Conditions  for coating 
plates and concentrations  of primary and secondary antibodies were optimized 
according to Rennard and co-workers (24, 25). Chick type I and lI collagens 
and rabbit  polyclonal  antibodies  against  chick type  I and II collagens were 
obtained  from Drs. T. Linsenmayer  and T. Schmid (Tufts University School 
of Medicine) (23). 50%  inhibition  was obtained  at  200-600  ng/ml for the 
homologous  collagen and 300 times more was needed for 50% inhibition with 
the heterologous collagen. The second antibody  used was goat anti-rabbit  IgG 
conjugated  to alkaline  phosphatase  (Sigma Chemical  Co.).  Microwell plates 
(Dynatech Laboratories, Inc., Alexandria, VA) were read with a Bio-Tek EIA 
reader (El 307; Bio-Tek Instruments, Inc., Burlington,  VT). Standard  curves 
were constructed with the ALLFIT program (26) modified for Apple computers 
(Biomedical Computing Technology Information Center,  Nashville, TN) for 
best fit parameters  for a sigmoid curve. The computed collagen concentration 
of diluted  medium samples was calculated  by substituting  into the  sigmoid 
equation  the absorption  value of the sample obtained in the ELISA assay and 
the fit parameters  obtained  from ALLFIT based upon the standard  collagens. 
Only  values  >15%  and  <85%  inhibition  (i.e.,  _+  2  SD)  were  considered 
significant. 
Proteoglycan Monomer Size 
Cultures were incubated with [3~S]sulfate  (100 ~tCi/ml) for 24 h. The medium 
was removed and precipitated  with 3 vol of 1.3% potassium  acetate in 95% 
ethanol at -20"C for 24 h. The samples were centrifuged (1,500 g, 15 rain) and 
the pellets were dissolved in 4 M guanidine-HC1, 0.05 M sodium acetate, pH 
5.8, plus the protease inhibitors,  5 mM benzamidine-HC1, 100 mM 6-amino- 
hexanoic  acid,  and  10  mM  EDTA.  Samples  were  first  passed  through a 
Sepharose CL-6B column equilibrated  with the above buffer to remove unin- 
corporated  sulfate. The macromolecular  materials  were pooled and aliquots 
were then passed through a Sepharose CL-2B gel filtration column in the above 
buffer (27). 
L  Abbreviations used in this paper:  ELISA, enzyme-linked immu- 
nosorbent assay. 
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with Hyaluronidase 
Chondrocytes  were incubated with fresh serum-containing  medium plus 50 
t~g/ml ascorbate and 100 #Ci/ml of either [3~S]sulfate  or [3H]proline.  After 24 
h the cells  were washed five times with PBS then incubated with either PBS or 
PBS containing Streptomyces  hyaluronidase  (1 mU/ml) at 37"C for 30 min. 
The incubation medium was then removed from the cell layer and centrifuged 
at  10,000 g. The supernatant was either analyzed for chondroitin sulfate by 
susceptibility  to chondroitinase  ABC digestion  or for proteins by precipitation 
with trichloroacetic  acid as described above. The remaining cell surface mac- 
romolecules were released with 0.25% trypsin and also analyzed as described 
above. 
RESULTS 
Pericellular Coats of Chondrocytes 
Chick  embryo  chondrocytes  produced  large  pericellular 
coats  that  can  be  visualized  by  exclusion of particles,  e.g., 
fixed  erythrocytes  (Fig.  I a).  These  coats  were  removed  by 
treatment with small amounts of Streptomyces hyaluronidase 
(Fig.  I b), which is specific for hyaluronate (16). At days 3-4 
of culture,  >95%  of the  cells displayed these  coats  with  a 
mean thickness of 12 #m (_ 2  SD). 
Since chondrocytes are labile in their expression of extra- 
cellular matrix, we checked that the culture conditions under 
which maximum coat formation was observed also allowed 
expression  of typical  chondrocyte  characteristics.  First,  the 
cells were seen to have the rounded to polygonal shape typical 
of chondrocytes (Fig.  l a).  Second,  these  chondrocytes pro- 
duced  three  to  four  times  more  chondroitin  sulfate  than 
hyaluronate (Table I C), and the chondroitin sulfate was pres- 
ent in large proteoglycan monomers. When chromatographed 
in 4 M  guanidine-HC1 on Sepharose CL-2B, these monomers 
FIGURE  1  Pericellular coats of chick embryo chondrocytes visualized by exclusion of formalin-fixed erythrocytes. Phase-contrast 
photomicrographs taken  15 min after the addition of erythrocytes. (a) Untreated chondrocytes. (b) Chondrocytes treated  with 
Streptomyces  hyaluronidase (1 mU/ml, 30 min, 37°C). Bar, 50/~m. 
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Matrix Macromolecule Synthesis by Chondrocytes in Primary  Culture 
Daysin culture 
2  3  4 
A  Coat/cell ratio  4.1  ±  0.4  5.1  +  0.6  2.9 +  0.2 
B  Cell surface GAG* 
Chondroitin sulfate  0.30 +- 0.04  0.24 ±  0.01  0.08 +  0.1 
Hyaluronate  0.05 _  0.01  0.06 ±  0.01  0.01  ±  0.003 
C  Medium GAG* 
Chondroitin sulfate  56 ±  2  77 ±  4  134 ±  10 
Hyaluronate  13 ±  4  26 ±  4  41  _  6 
D  Medium collagen* 
Type II  0.32 ±  0.02  0.64 ±  0.06  1.10 ±  0.06 
Type l  <0.1  <0.1  <0.1 
Macromolecule synthesis and coat/cell ratio were determined as described  in Materials and Methods.  Synthesis of glycosaminoglycan (GAG) was measured 
by the incorporation of [3H]acetate and collagen by ELISA. 
* cpm x  1061#g  DNA. 
~g/~g DNA. 
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FIGURE  2  Gel  chromatography  of  proteoglycan  monomers  on 
Sepharose CL-2B. 3SS-labeled media from chondrocyte (-) and 3T3 
cell (--) cultures  were precipitated  in ethanol and then dissolved  in 
4 M guanidine-HCI  plus protease inhibitors. We removed unincor- 
porated [3SS]sulfate  by passing through a gel filtration column before 
chromatography on CL-2B. 
were shown to have a Kav of 0.3 (Fig. 2), similar to the value 
obtained by others for chondrocytes (27). In comparison, 3T3 
cells were shown to produce much smaller proteoglycans with 
a Kay of 0.7. The third criterion used was the type of coUagen 
synthesized. SDS PAGE revealed only one band in the region 
of collagen alpha-chains (Fig. 3). This suggested strongly that 
type  II,  not  type  I,  collagen  was  being  produced  (28).  In 
addition, no band was observed in the collagen gamma-chain 
region in the gel performed under nonreducing conditions, 
indicating that no type III collagen was produced. The identity 
of the type II collagen was confirmed by ELISA (Table  I), 
which showed the presence of type II and not type I collagen. 
Thus we conclude that the cells in these cultures were differ- 
entiated chondrocytes. 
Chondrocyte  Spreading and Coat Formation 
To characterize the kinetics of  coat formation, we measured 
two parameters. These were the area within the cell perimeter 
(cell area), which is a measure of the degree of spreading, and 
the area within the coat perimeter (coat +  cell area). The ratio 
of these two parameters  (coat/cell  ratio)  provides a  relative 
FIGURE  3  Autoradiograph of an SDS gel of proteins from  pepsin- 
digested  medium  of  chondrocyte  culture  after  incubation  with 
[3H]proline. Lane a, after reduction; lane b, without reduction; lane 
c, standard type I collagen from rat tail tendon. 
estimate of the coat thickness. 
When primary cultures were observed  1 h  after we seeded 
cells onto tissue culture dishes, the chondrocytes were seen to 
have attached to the substratum but no significant coats were 
visible (Fig. 4 a). After 4 h (Fig. 4 b) coats were clearly evident 
around most of the chondrocytes, but the cells had not yet 
spread  to  any  extent.  Quantitation  by  morphometry  con- 
firmed that the initial rate of coat formation was greater than 
that  of cell spreading  (Fig.  5,  inset).  Over the next  3  d  the 
coats continued  to  increase  in  size,  giving rise  to  coat/cell 
ratios that changed from approximately 2 at 4  h to approxi- 
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chondrocytes from the cartilage  matrix,  we plated the cells  in  serum-containing  medium. Cultures  were removed from the 
incubator at various time intervals and coats were visualized by addition of fixed erythrocytes.  Phase-contrast photomicrographs 
of the primary cultures of chondrocytes were taken at the following  times after plating of the cells: (a) 1 h; (b) 4 h; (c) 2 d; and (d) 
6 d. Bar, 50 #m. 
mately 4  at 3 d  (Fig.  6).  Also, the cells  spread within these 
newly forming coats (Figs. 4c and 5). After 4 d the size of the 
coats decreased but the cells continued to spread until day 5- 
6, after which virtually no coat was visible (Figs. 4d and 5). 
Thus the coat/cell ratio approached 1.0 by day 7-10 of  culture 
(Fig. 6). 
When the chondrocytes were subcultured, large coats were 
seen only if the cells were passaged before 4 d (Fig. 6). These 
chondrocytes, subcuttured prior to 4 d, spread more quickly 
than the chondrocytes in primary cultures. Also they formed 
and lost their coats more rapidly (Fig.  6). Therefore, the size 
of the chondrocyte coat is both time and passage dependent. 
Synthesis  of  extracellular  matrix  macromolecules  also 
changed with time in culture and with passage. The amount 
of hyaluronate  and  chondroitin  sulfate produced  per  24  h 
increased with time during primary culture (Table I C). Only 
a  small portion of these glycosaminoglycans was retained at 
the cell surface but this proportion decreased with time (Table 
IB) in parallel with the decrease in coat size (Table IA). The 
level of type II collagen remained relatively high throughout 
this  period;  no  type  I  collagen  was  detected  (Table  ID). 
Glycosaminoglycan and collagen synthesis were also exam- 
ined at a  fixed interval of subculture (3  d) after passage at 
various times of primary culture (2, 3, and 4 d). It was found 
that the later the day of initiation of the subculture, the higher 
the synthesis of hyaluronate and chondroitin sulfate and the 
lower the synthesis of type II collagen; no type I collagen was 
detected. Once more, a  small proportion of each glycosami- 
noglycan was retained at the cell surface and this proportion 
varied for each glycosaminoglycan with time of passage (data 
not  shown).  Correlation  coefficients between  these  various 
metabolic parameters and coat size were calculated. No sig- 
nificant correlation was found  for any of these parameters 
except cell surface glycosaminoglycans (P <  0.5). 
Release of Cell Surface Macromolecules 
with Hyaluronidase 
To determine whether proteoglycans and collagen are re- 
tained in the coat by interaction with hyaluronate, we treated 
the cells with Streptomyces  hyaluronidase and measured the 
macromolecules released as a consequence of degradation of 
the  pericellular coat.  The  cells were labeled  for 24  h  with 
either [3H]proline or [35S]sulfate. After washing the cells with 
PBS to remove secreted macromolecules and unincorporated 
isotope,  we  incubated  the  monolayers  for  0.5  h  with  or 
2  I  1 8  THE  JOURNAL OF  CELL BIOLOGY " VOLUME 99,  1984 without Streptomyces  hyaluronidase. The residual cell surface 
material was then released with trypsin. In a parallel experi- 
ment, we found that the hyaluronidase treatment completely 
removed the coat. The hyaluronidase treatment caused the 
release of ~60% of  35S-labeled cell surface glycosaminoglycans 
and  -  10%  of the  [3H]proline-labeled proteins  (Table  II). 
Greater than 90% of the 35S-labeled glycosaminoglycans re- 
leased was chondroitin sulfate. Virtually none of the released 
protein was  collagen.  Because >90%  of the  proteins were 
retained on the cell surface after hyaluronidase treatment, it 
is unlikely that the release of the chondroitin sulfate was due 
to a protease contaminant in the hyaluronidase. It is probable 
that the small amount of protein that is released is comprised 
mainly of the link protein and core protein associated with 
the released chondroitin sulfate-proteoglycan. 
Inhibition of Coat  Formation by Monensin 
and Cycloheximide 
Since much higher levels of chondroitin sulfate than hyalu- 
ronate were  found to  be  associated  with  the  chondrocyte 
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FIGURE  5  Morphometric  measurements of  the  time  course  of 
chondrocyte spreading and coat formation. Coats were visualized 
at various times after plating of the cells as described in Fig. 4. The 
cell areas (O) (representative  of cell spreading) and coat + cell areas 
(O) were measured by tracing randomly selected photographs of 
the cultures on a digitizing graphics tablet. (inset)  Values from one 
embryo preparation (30 to 50 measurements  for each value). Values 
with  SE  bars  were  from  three  embryo  preparations (60  to  150 
measurements for each value). 
surface (Table IB), we investigated whether the structure of 
the coat was dependent upon chondroitin sulfate-proteogly- 
can in addition to hyaluronate. Because enzymes that degrade 
chondroitin sulfate also degrade hyaluronate, we approached 
this problem pharmacologically, exposing the chondrocytes 
to various concentrations of monensin and cycloheximide. In 
parallel experiments we measured coat size (Fig.  7) and in- 
corporation of isotopic precursor into cell surface glycosami- 
noglycans (Fig. 8). We found that both monensin and cyclo- 
heximide inhibited  coat  formation and glycosaminoglycan 
synthesis in a dose-dependent manner. However, monensin 
was  more potent in inhibiting both coat formation (Fig.  7) 
and hyaluronate synthesis (Fig. 8) than cycloheximide. Both 
cycloheximide and  monensin inhibited chondroitin sulfate 
synthesis  at  a  much  lower concentration  than  needed  to 
inhibit hyaluronate synthesis (Fig. 8) and coat formation (Fig. 
7). At 0.1 ~M, chondroitin sulfate synthesis was almost com- 
pletely inhibited by both drugs. However, at this dose monen- 
sin caused only a 50% inhibition of hyaluronate synthesis and 
coat formation whereas cycloheximide caused virtually no 
inhibition. Comparison of cell surface hyaluronate synthesis 
and coat size showed that they were linearly correlated (r = 
0.98), but no significant correlation (r =  0.2) was found for 
chondroitin sulfate (Fig. 9). 
DISCUSSION 
In  this  study,  we  have  shown  that  chondrocytes in  early 
primary cultures exhibit prominent pericellular coats that are 
equivalent in size to the pericellular plus territorial matrices 
surrounding chondrocytes in vivo (2, 3). The integrity of  these 
coats is dependent on hyaluronate and does not appear to be 
dependent on proteoglycan. This was  shown in  two ways; 
first, by the sensitivity of the coats to low concentrations of 
Streptomyces hyaluronidase (Fig.  1), and second, by the dif- 
ferential inhibition of coat formation by drugs  that block 
hyaluronate and chondroitin sulfate-proteoglycan synthesis at 
different doses (Figs. 7 and 8). 
Although hyaluronate is responsible for coat integrity, a 
major cell surface component of the chondrocytes is chon- 
droitin sulfate-proteoglycan (Table IB). We have shown here 
that 50-60% of this proteoglycan is released from the chon- 
drocyte surface by treatment with Streptomyces  hyaluronidase 
(Table  II).  This  finding  agrees with  past  studies  by other 
investigators (7,  8) showing that addition of hyaluronate to 
chondrocytes in culture caused displacement of newly synthe- 
sized proteoglycan from the chondrocyte surface. It has also 
been shown that hyaluronate associated with the chondrocyte 
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FIGURE  6  Time course of changes in coat/cell 
ratios for chondrocytes in primary cultures (Q) 
and first passage cultures (O). The coat +  cell 
and cell areas were quantitated as described in 
Fig. 5; the ratio of these parameters was then 
plotted against  days  in  culture.  Each experi- 
ment (EXP)  was from a different preparation of 
chick embryos. The  chondrocytes were sub- 
cultured on day 3 in EXP I, day 1 in EXP 2, and 
days 2 and 7 in EXP 3. 
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Effect of Hyaluronidase  on the Release of Cell Surface Macromolecules 
Released cpm (x 10  -3) 
-Hase  +Hase  -Hase  +Hase 
[3sS]Sulfat e  Total GAG  Chondroitin sulfate 
Inc. med.  20+_2  189+6  11  +2  157+  11 
Trypsinate  282 +  26  112 +  11  262 +  21  100 _  9 
%  Released by Hase  56  57 
[3H]Prolin  e  Total protein  Collagen 
Inc. med.  23.1 +- 4.6  32.0 _  2.0  0.3 _+ 0.1  0.3 +  0.1 
Trypsinate  110.4 +- 6.4  89.2 +- 6.3  0.4 _  0.1  0.6 +  0.3 
%  Released by Hase  9  0 
Hase, Streptomyces hyaluronidase (1 mU/ml); GAG, glycosaminoglycan; Inc. reed.,  incubation medium (PBS). % released by Hase: 
[  Inc.  med. (+Hase)  Inc. med. (-Hase)  ] 
100 x  Trypsinate (+Hase)  +  Inc.  med. (+Hase)  Trypsinate ~'H~+-I~c.-~ed.  (-Uasei 
Values are means :1: SE from three separate cultures.  Chondrocytes were labeled for 24 h with either 100/~Ci/ml  [3SS]sulfate or 100/~Ci/ml  [3H]proline. Cell 
layers  were washed twice with  PBS buffer and  incubated with  or without  hyaluronidase for 0.5  h at 37°C,  and  incubation  medium  was  collected and 
centrifuged. The cells were released by trypsin (0.25%) and separated from the trypsinate by centrifugation. Chondroitin sulfate and collagen were quantitated 
by susceptibility to digestion by specific enzymes as described in Materials and Methods. 
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FIGURE  7  Effects of monensin and cycloheximide on chondrocyte 
coat formation. After 2 d in culture, chondrocytes were exposed to 
various concentrations of monensin (I-I) and cycloheximide (A) for 
48 h. The coat/cell ratios were determined as in Fig. 6. 
surface is able to bind exogenously added proteoglycan (9). 
These  various studies  indicate  that  proteoglycan  aggregate 
formation takes place in the pericellular (and/or territorial) 
matrix of chondrocytes, and that the aggregates are held to 
the chondrocyte surface via cell surface-bound hyaluronate. 
Currently we are attempting to determine the mode of inter- 
action of hyaluronate with the chondrocyte surface. 
Although it is clear that much of the proteoglycan at the 
chondrocyte surface is retained via interaction with hyaluro- 
hate, there is also a  considerable proportion (40-50%) that 
seems to be held by a different mechanism since it remains 
bound  to  the  chondrocytes  after  digestion  with  sufficient 
Streptomyces  hyaluronidase to remove their pericellular coats 
(Table II). Previous studies with cells other than chondrocytes 
have  provided  precedent  for  at  least  three  other  possible 
mechanisms for binding of proteoglycans to the surface of 
cells. First, specific interactions of glycosaminoglycan chains 
with binding proteins on the surface of various cell types have 
been demonstrated for heparan sulfate (29, 30) and for hyalu- 
ronate  (31,  32).  Such  interactions  can  occur directly with 
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FIGURE  8  Effects of monensin and cycloheximide on cell surface 
glycosaminoglycan synthesis. The chondrocytes were exposed to 
the drugs with the same regimen as in  Fig.  7.  For the last 24 h  of 
exposure to the drugs,  [3H]acetate (100 pCi/ml) was added to the 
medium and incorporation into hyaluronate, and chondroitin sul- 
fate in the trypsinate fraction from washed cells was measured as 
described in the text. Effect of cycloheximide on synthesis of cell 
surface  hyaluronate (A)  and  cell  surface  chondroitin  sulfate  (,L). 
Effect of monensin on synthesis of cell surface hyaluronate (17) and 
cell  surface  chondroitin  sulfate  (11). Values  are  the  means  from 
triplicate cultures. 
plasma membrane receptors (33) or indirectly through other 
cell surface-hound proteins such as fibronectin (34).  Second, 
fibroblast proteoglycans have been found to bind  via their 
protein core to receptors on the surface of fibroblasts (35). 
Third, evidence has been obtained for direct intercalation of 
a hydrophobic region of the protein core of heparan sulfate 
proteoglycan in the plasma membrane of various cell types 
(36-38). Binding of some of the proteoglycan to the chondro- 
cyte surface by a mechanism analogous to any of these would 
explain its retention after Streptomyces hyaluronidase treat- 
ment of the cells (Table II). 
A puzzling feature of the pericellular coats described herein 
is their transient nature. We have shown that the coats begin 
to form within a few hours but take 3-4 d to reach full size O4 
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COAT "CELL RATIO 
Correlation  of  cell  surface  glycosaminoglycan  (GAG) 
synthesis and coat size. The values for glycosaminoglycan synthesis 
are from Fig. 8 and those for coat/cell ratio are from Fig. 7. Open 
symbols are hyaluronate (HA) and closed symbols are chondroitin 
sulfate (C5). 
(Figs. 4 and 5). During this time, the chondrocytes spread on 
the culture substratum while encased in their coats.  Subse- 
quently, however, the coat diminishes in size until, at 7-10 d, 
it is no longer discernible (Figs.  4 and 5). If the chondrocytes 
are subcultured early in the primary culture, the coat forms 
again but is lost more rapidly than if left in primary culture. 
Regardless  of the  time  of passaging,  the  pericellular  coat 
diminishes after 4-5 d of"total" culture time. If subcultured 
at or subsequent to this time,  the resulting coats are  much 
smaller than in the primary (Fig. 6). We have found that the 
kinetics of formation and decay of pericellular coats differs 
considerably  for  different  cell  types.  For  example,  coats 
around rat fibrosarcoma ceils (18) reform each time the cells 
are subcultured, but they form and decay more rapidly than 
those of the chondrocytes described in the present study. The 
physiological significance of the formation and loss of coats 
is not known. However, it is possible that this turnover may 
reflect  the differentiated state of the cells.  It is known that 
chondrocytes in  culture gradually change their phenotypic 
properties (39-42) unless cultured under stringent conditions 
including extremely high cell densities (43-46).  To observe 
the pericellular coats by the method employed in this study, 
it was necessary to culture the chondrocytes at subconfluent 
densities. Thus it is possible that the decrease in size of the 
coats with time and passaging may be a sign of impending 
dedifferentiation. Consistent with this possibility, we observed 
that the synthesis of type II collagen decreased greatly in the 
subcultures performed  late in primary culture, a  condition 
where only small coats formed (Fig. 6). 
In  conclusion,  we  have  shown that  chick  embryo  tibia 
chondrocytes exhibit large pericellular coats whose structural 
integrity is dependent on hyaluronate. Although proteoglycan 
appears to be a  major component of these coats,  it is not 
necessary for their integrity and is in large part retained in the 
coats via interaction with hyaluronate. It will be of consider- 
able interest to determine in more detail the structure and 
interactions of the components of these coats, the changes 
that occur in these components during chondrogenesis and 
osteogenesis, and the mechanism of retention of hyaluronate 
and proteoglycan at the plasma membrane of chondrocytes. 
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